Dr Lal Path Labs, India’s largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid rising health awareness in the country.
Nifty may hit 24,060 before recovery, IT breakout imminent: Geojit’s Anand James
Despite Friday’s recovery attempt, technical charts are painting a cautious picture for Nifty in the coming week. Anand James, Chief Market Strategist at Geojit Investments